One reason is the fact that much research related to ovarian cancer has focused on strategies combining chemotherapy with ...
Epithelial ovarian cancer is the fourth ... Several treatment alternatives have been investigated, such as intraperitoneal chemotherapy, alternative doublets and triplet regimens, in the effort ...
A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...
Overall, surgical de-escalation in gynecologic oncology increased from 2004 to 2020, with a growing shift toward minimally ...
Delays and errors in the care of 38-year-old cancer patient Carla Smith at the Queen Elizabeth Hospital in King's Lynn have been slammed ...
NCCN—an alliance of leading cancer centers—publishes a new resource to inform people about the latest recommendations around ...
They were used on five patients, and four of them are now either in remission or cancer-free. Read more at straitstimes.com.
Daly, MD, PhD, FACP, Fox Chase Cancer Center; and Chair of the NCCN Guidelines ® Panel for Genetic/Familial High-Risk Assessment: Breast, Ovarian ... of the natural history of cancer, the ...
Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...